Clin Breast Cancer. 2003 Feb;3(6):381-90.

Prognostic and predictive indicators in operable breast cancer.

Morabito A, Magnani E, Gion M, Sarmiento R, Capaccetti B, Longo R, Gattuso D, Gasparini G.

Source

Division of Medical Oncology, Azienda Ospedaliera San Filippo Neri, Rome, Italy.

Abstract

Because of its biological heterogeneity and wide spectrum of responsiveness to different treatments, breast cancer is a complex disease of difficult clinical management. Over the past several years, knowledge of the molecular mechanisms regulating normal and aberrant cell growth leading to cancer has been enhanced. These advances have enabled the identification of an increasing number of surrogate biomarkers, which have been correlated with prognosis or used as predictors of response to specific treatments. Axillary nodal status, age, tumor size, pathologic grade, and hormone receptor status are the established prognostic and/or predictive factors for selection of adjuvant treatments. The role of new biomarkers, such as p53, HER2/neu, angiogenesis, and the proliferation index value, is promising; however, the clinical value of their determination must be provided by prospective clinical studies.

PMID:: 12636883; [PubMed - indexed for MEDLINE]

Free full text

LinkOut - more resources

Full Text Sources

Medical

Breast Cancer - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Related citations

The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma. [Tumori. 2005]
The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma.
Erdem O, Dursun A, Coşkun U, Günel N. Tumori. 2005 Jan-Feb; 91(1):46-52.
Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. [Mod Pathol. 2002]
Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH. Mod Pathol. 2002 Aug; 15(8):853-61.
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. [Breast Cancer Res. 2008]
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast.
von Minckwitz G, Sinn HP, Raab G, Loibl S, Blohmer JU, Eidtmann H, Hilfrich J, Merkle E, Jackisch C, Costa SD, et al. Breast Cancer Res. 2008; 10(2):R30. Epub 2008 Apr 1.
Review Overview of resistance to systemic therapy in patients with breast cancer. [Adv Exp Med Biol. 2007]
Review Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Adv Exp Med Biol. 2007; 608:1-22.
Review Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. [Ann Surg. 2002]
Review Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years.
Mirza AN, Mirza NQ, Vlastos G, Singletary SE. Ann Surg. 2002 Jan; 235(1):10-26.

See reviews... See all...

Cited by 3 PubMed Central articles

Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast. [World J Surg Oncol. 2010]
Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast.
Bae JS, Choi JS, Baik SH, Park WC, Song BJ, Kim JS, Lim Y, Jung SS. World J Surg Oncol. 2010 Apr 21; 8:32. Epub 2010 Apr 21.
The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. [Breast Cancer Res. 2005]
The expression of the ubiquitin ligase subunit Cks1 in human breast cancer.
Slotky M, Shapira M, Ben-Izhak O, Linn S, Futerman B, Tsalic M, Hershko DD. Breast Cancer Res. 2005; 7(5):R737-44. Epub 2005 Jul 19.
Predicting aggressive outcome in T1N0M0 breast cancer. [Br J Cancer. 2004]
Predicting aggressive outcome in T1N0M0 breast cancer.
Kronqvist P, Kuopio T, Nykänen M, Helenius H, Anttinen J, Klemi P. Br J Cancer. 2004 Jul 19; 91(2):277-81.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Prognostic and predictive indicators in operable breast cancer.
Prognostic and predictive indicators in operable breast cancer.
Clin Breast Cancer. 2003 Feb ;3(6):381-90.

PubMed
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical r...
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.
Breast Cancer Res. 2010 ;12(1):R12. Epub 2010 Feb 11 .

PubMed
Factors influencing the use of breast reconstruction postmastectomy: a National ...
Factors influencing the use of breast reconstruction postmastectomy: a National Cancer Database study.
J Am Coll Surg. 2001 Jan ;192(1):1-8.

PubMed
ABL-N-induced apoptosis in human breast cancer cells is partially mediated by c-...
ABL-N-induced apoptosis in human breast cancer cells is partially mediated by c-Jun NH2-terminal kinase activation.
Breast Cancer Res. 2010 ;12(1):R9. Epub 2010 Jan 25 .

PubMed
The molecular and cellular biology of HER2/neu gene amplification/overexpression...
The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer.
Cancer Treat Res. 2000 ;103:57-75.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Prognostic and predictive indicators in operable breast cancer.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Libraries

Supplemental Content

Related citations

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information